Sana Biotechnology (SANA) Assets (2020 - 2026)
Sana Biotechnology (SANA) posted Assets of $373.6 million for Q1 2026, down 10.39% sequentially from $416.9 million in Q4 2025, and down 16.14% YoY from $445.5 million in Q1 2025.
Sana Biotechnology (SANA) Assets (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Assets for 7 years, with the latest figure at $373.6 million in Q1 2026.
- Quarterly Assets fell 16.14% year-over-year to $373.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373.6 million (down 16.14% YoY) and the FY2025 annual result came in at $416.9 million, down 16.79% from the prior year.
- Assets slipped to $373.6 million in Q1 2026 per SANA's latest filing, from $416.9 million in the prior quarter.
- Over five years, Assets peaked at $1.0 billion in Q1 2022 and troughed at $361.6 million in Q2 2025.
- A 5-year average of $634.3 million and a median of $618.7 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets slipped 8.78% in 2024, then plunged 41.54% in 2025.
- Over 5 years, Assets stood at $822.7 million in 2022, then tumbled by 31.29% to $565.3 million in 2023, then fell by 11.37% to $501.0 million in 2024, then decreased by 16.79% to $416.9 million in 2025, then retreated by 10.39% to $373.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $373.6 million, $416.9 million, and $435.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 431.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 431.52 Mn |
| Mar 31, 2026 | 373.59 Mn |
| Dec 31, 2025 | 416.89 Mn |
| Sep 30, 2025 | 435.43 Mn |
| Jun 30, 2025 | 361.65 Mn |
| Mar 31, 2025 | 445.47 Mn |
| Dec 31, 2024 | 501.02 Mn |
| Sep 30, 2024 | 559.39 Mn |
| Jun 30, 2024 | 618.67 Mn |
| Mar 31, 2024 | 681.38 Mn |
| Dec 31, 2023 | 565.30 Mn |
| Sep 30, 2023 | 631.44 Mn |
| Jun 30, 2023 | 707.15 Mn |
| Mar 31, 2023 | 746.93 Mn |
| Dec 31, 2022 | 822.72 Mn |
| Sep 30, 2022 | 898.10 Mn |
| Jun 30, 2022 | 971.09 Mn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 1.13 Bn |
| Sep 30, 2021 | 1.23 Bn |